Cargando…
Development of targeted adjuvants for HIV-1 vaccines
Finding new adjuvants is an integrated component of the efforts in developing an effective HIV-1 vaccine. Compared with traditional adjuvants, a modern adjuvant in the context of HIV-1 prevention would elicit a durable and potent memory response from B cells, CD8(+) T cells, and NK cells but avoid o...
Autores principales: | Liu, Jun, Ostrowski, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594534/ https://www.ncbi.nlm.nih.gov/pubmed/28893282 http://dx.doi.org/10.1186/s12981-017-0165-8 |
Ejemplares similares
-
P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine
por: Liu, J, et al.
Publicado: (2009) -
Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations
por: Lee, Branden, et al.
Publicado: (2023) -
Promising Adjuvants and Platforms for Influenza Vaccine Development
por: Zhu, Wandi, et al.
Publicado: (2021) -
Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022) -
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants
por: Franco, Ana Rita, et al.
Publicado: (2021)